EQUITY INVESTMENT (Tables)

6 Months Ended

Dec. 31, 2025

Investments, Debt and Equity Securities [Abstract]

Schedule of other nonoperating income

The Company recognized a loss on sale of $201.9 included in Other expense (income), net in the Condensed Consolidated Statements of Operations for the three and six months ended December 31, 2025.

Cash proceeds	$	750.0
Wella Distribution Rights	58.0
Total consideration	808.0
Less:
Wella investment carrying value	1,003.0
Transaction and other costs to sell	6.9
Loss on sale of Wella investment	(201.9)

Schedule of equity investments

The Company's equity investment, which is presented within Equity investment in the Condensed Consolidated Balance Sheets, is summarized as follows:

	December 31, 2025		June 30, 2025
Equity investment at fair value:
Wella (a)	—		1,002.0
Total equity investment	$	—	$	1,002.0

The following table presents summarized financial information of the Company’s equity method investees for the period ending December 31, 2025. Amounts presented represent combined totals at the investee level and not the Company’s proportionate share:

	Three Months Ended December 31,				Six Months Ended December 31,
	2025		2024		2025		2024
Net revenues	$	819.0	$	737.9	$	1,526.9	$	1,393.4
Gross profit	$	567.3	$	507.4	$	1,054.6	$	953.1
Operating income	$	129.1	$	109.1	$	191.8	$	147.8
Income before taxes	$	87.7	$	51.3	$	109.3	$	48.8
Net income (loss)	$	59.9	$	19.2	$	66.0	$	(6.9)

Amounts included for the three and six months ending December 31, 2025 related to the investment in Wella include activity through the sale of the Wella investment on December 18, 2025.